Novartis (NVS) Misses Q4 EPS by 12c

Novartis (NYSE: NVS) reported Q4 EPS of $1.53, $0.12 worse than the analyst estimate of $1.65. Revenue for the quarter came in at $11.42 billion versus the consensus estimate of $11.9 billion.

For earnings history and earnings-related data on Novartis (NVS) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c